Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- CheckyesterdayChange DetectedDifference0.3%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a phase II trial for cabozantinib in treating various pediatric tumors, which included objectives, inclusion and exclusion criteria, and treatment protocols. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference43%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 23, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.4%
- Check37 days agoChange DetectedThe page has been updated to include information on Adrenocortical Carcinoma and reflects a new revision version. The last update date has changed to March 25, 2025, indicating a more recent update compared to the previous version.SummaryDifference0.4%
- Check44 days agoChange DetectedDifference0.5%
Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.